Harte Hanks, Inc.
HHS
$4.93
-$0.10-1.99%
| Weiss Ratings | HHS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | D- | |||
| Rating Factors | HHS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Excellent | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | HHS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.69 | |||
| Price History | HHS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -1.60% | |||
| 30-Day Total Return | -4.64% | |||
| 60-Day Total Return | -14.26% | |||
| 90-Day Total Return | -32.47% | |||
| Year to Date Total Return | -3.33% | |||
| 1-Year Total Return | -34.18% | |||
| 2-Year Total Return | -47.50% | |||
| 3-Year Total Return | -29.87% | |||
| 5-Year Total Return | 94.09% | |||
| 52-Week High % Change | -44.42% | |||
| 52-Week Low % Change | 5.69% | |||
| Price | HHS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $8.87 | |||
| 52-Week Low Price | $4.66 | |||
| 52-Week Low Price (Date) | Mar 07, 2025 | |||
| 52-Week High Price (Date) | Jul 03, 2024 | |||
| Valuation | HHS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 35.93M | |||
| Enterprise Value | 55.22M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -4.12 | |||
| Earnings Per Share Growth | -235.90% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.19 | |||
| Price/Book (Q) | 1.72 | |||
| Enterprise Value/Revenue (TTM) | 0.29 | |||
| Price | $4.93 | |||
| Enterprise Value/EBITDA (TTM) | -2.00 | |||
| Enterprise Value/EBIT | -1.73 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | HHS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 7.40M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | $0.85 | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | $0.85 | |||
| Company Info | HHS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 512 434 1100 | |||
| Address | 1 Executive Drive Chelmsford, MA 01824 | |||
| Website | www.hartehanks.com | |||
| Country | United States | |||
| Year Founded | 1923 | |||
| Profitability | HHS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -16.97% | |||
| Profit Margin | -15.90% | |||
| Management Effectiveness | HHS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -18.18% | |||
| Return on Equity | -- | |||
| Income Statement | HHS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 187.60M | |||
| Total Revenue (TTM) | 187.60M | |||
| Revenue Per Share | $25.36 | |||
| Gross Profit (TTM) | -5.91M | |||
| EBITDA (TTM) | -27.56M | |||
| EBIT (TTM) | -31.85M | |||
| Net Income (TTM) | -29.84M | |||
| Net Income Avl. to Common (TTM) | -29.84M | |||
| Total Revenue Growth (Q YOY) | 1.08% | |||
| Earnings Growth (Q YOY) | -77.02% | |||
| EPS Diluted (TTM) | -4.12 | |||
| EPS Diluted Growth (Q YOY) | -75.75% | |||
| Balance Sheet | HHS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 5.94M | |||
| Cash Per Share (Q) | $0.80 | |||
| Total Current Assets (Q) | 53.82M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 21.05M | |||
| Current Ratio (Q) | 1.457 | |||
| Book Value Per Share (Q) | $2.86 | |||
| Total Assets (Q) | 108.13M | |||
| Total Current Liabilities (Q) | 36.94M | |||
| Total Debt (Q) | 25.23M | |||
| Total Liabilities (Q) | 87.08M | |||
| Total Common Equity (Q) | 21.05M | |||
| Cash Flow | HHS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -3.95M | |||
| Cash from Financing (TTM) | -411.00K | |||
| Net Change in Cash (TTM) | -7.84M | |||
| Levered Free Cash Flow (TTM) | -17.33M | |||
| Cash from Operations (TTM) | -2.67M | |||
